By Jude Ikedi

In recent years, Nigeria’s pharmaceutical sector has been quietly embracing technology to solve one of the country’s most persistent healthcare challenges: access to essential medicines. Hospitals and pharmacies, particularly in Northern Nigeria, are adopting data-driven sales and supply models to improve forecasting, reduce stock-outs, and ensure continuity of care for patients with chronic conditions.

The shift comes as healthcare providers and pharmaceutical companies acknowledge that traditional inventory management systems are often insufficient to meet the needs of a rapidly growing population. Emily Enij Akande, who has coordinated data-driven initiatives at Novartis and Evans Therapeutics, explained that analytics is now central to stabilising supply chains for cardiovascular, diabetes, and other long-term therapies.

“Stock-outs were a persistent problem,” Emily said. “Patients would come to the pharmacy only to find their medications unavailable, sometimes for weeks. By integrating predictive analytics into distribution planning, we can anticipate demand more accurately and allocate resources where they are needed most.”

Her work involves collating data from multiple facilities, identifying patterns in patient demand, and coordinating with hospitals to streamline inventory control. This approach has resulted in more predictable stock levels and fewer interruptions to patient treatment, a development welcomed by both physicians and pharmacists.

“Pharmacists now have the capacity to focus on patient care rather than chasing supply,” Emily noted. “They can counsel patients on adherence, monitor therapy outcomes, and collaborate more closely with doctors to manage chronic conditions.”

Industry observers say Nigeria’s embrace of analytics mirrors global trends in healthcare logistics. Predictive models and real-time reporting systems are becoming standard in countries with robust pharmaceutical infrastructure, and local adoption signals a step toward modernising the sector.

Emily stressed, however, that the technology is only one part of the solution. “Analytics must be paired with effective communication and collaboration across the supply chain,” she said. “Manufacturers, distributors, and hospitals need to act on the insights data provides. Otherwise, the information alone cannot improve patient outcomes.”

Early results suggest that the new approach is making a tangible difference. Hospitals in Lagos, Kano, and Kaduna report fewer stock-outs, improved access to chronic therapies, and smoother operational workflows. For patients, this translates into uninterrupted treatment and reduced risk of complications associated with therapy gaps.

Experts note that the COVID-19 pandemic accelerated the adoption of digital tools across the healthcare sector. Supply chain disruptions highlighted vulnerabilities and underscored the need for data-driven decision-making. Today, predictive analytics not only improves access to medications but also helps facilities plan more effectively for future demand.

“World Health Day is an important reminder of the value of equitable access to healthcare,” Emily said. “Data-driven approaches allow us to ensure that patients, no matter where they live, receive the medicines they need when they need them. This is a critical step in reducing preventable illness and improving health outcomes.”

As Nigeria continues to strengthen its healthcare system, the integration of analytics in pharmaceutical operations may well serve as a model for other low- and middle-income countries. Emily’s work demonstrates how evidence-based planning can transform service delivery, reduce inefficiencies, and, ultimately, save lives.